Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-06-10

FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)

View source ↗

Summary

The FDA approved a supplemental application for levothyroxine sodium submitted by Lannett Company, Inc., authorizing continued marketing of a generic levothyrox…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)